arrow
J

Jonas Alex Morales Saute

federal university of rio grande do sul
H指数:35
被引数:3,009

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Unbiased bioinformatic and clinical analysis identifies glial fibrillary acidic protein as a potential biomarker in spinal muscular atrophy

无偏生物信息学和临床分析鉴定胶质纤维酸性蛋白为脊髓性肌萎缩症的潜在生物标志物

2026-09-110
OAAI
Clinical Characterization of Patients With 5q Spinal Muscular Atrophy Types 2 and 3 in Brazil: A Cross-Sectional Observational Study

巴西5q型脊髓性肌萎缩症2型和3型患者的临床特征:一项横断面观察研究

2026-05-080
OA
Safety and tolerability of onasemnogene abeparvovec for patients with spinal muscular atrophy weighing ≤17 kg and ≤24 months old from OFELIA, a phase 4, open-label, multicenter, non-randomised, interventional study

来自OFELIA(一项第4期、开放标签、多中心、非随机化、干预性研究)的数据显示,onasemnogene abeparvovec在体重≤17 kg且年龄≤24个月的脊髓性肌萎缩症患儿中的安全性与耐受性。

2025-07-280
PRE
An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants

一种少突胶质细胞沉默子元件构成了层粘连蛋白B1结构变异的致病性影响

2025-02-051
OA
Clinicogenetic characterization and response to disease-modifying therapies in spinal muscular atrophy: real-world experience from a reference center in Southern Brazil

临床遗传学特征及对疾病修饰疗法的应答在脊髓性肌萎缩症中的研究:来自南巴西一家参考中心的真实世界经验

2025-01-011
OAAI
Epidemiological characterization of rare diseases in Brazil: A retrospective study of the Brazilian Rare Diseases Network

巴西罕见病的流行病学特征:巴西罕见病网络的回顾性研究

2024-10-302
OAAI
Evaluation of chenodeoxycholic acid treatment in adult patients with cerebrotendinous xanthomatosis: A randomized, placebocontrolled Phase 3 study (RESTORE)

评估鹅去氧胆酸治疗成年脑腱黄瘤病患者: 一项随机,安慰剂对照的3期研究 (RESTORE)

2024-04-011
PRE
Serum myostatin as a candidate disease severity and progression biomarker of spinal muscular atrophy

血清肌肉生长抑制素作为脊髓性肌萎缩症的候选疾病严重程度和进展生物标志物

2024-02-281
OAAI
Characterization of the profile of patients with spinal muscular atrophy types 2 and 3 being followed up in the Brazilian public health system
2023-12-010
PRE
Pathological variants in TOP3A cause distinct disorders of mitochondrial and nuclear genome stability
2023-04-049
OAAI
Biallelic Variants in the Ectonucleotidase ENTPD1 Cause a Complex Neurodevelopmental Disorder with Intellectual Disability, Distinct White Matter Abnormalities, and Spastic Paraplegia
2022-05-284
OA
Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias
2021-11-1513
OAAI